.After increasing $213 million in 2023-- some of the year's largest exclusive biotech rounds-- Tome ...
.Welcome to recently's Chutes & Ladders, our summary of significant leadership hirings, firings a...
.Equity capital backing right into biopharma rose to $9.2 billion across 215 handle the second quart...
.Bicara Therapies as well as Zenas Biopharma have provided fresh catalyst to the IPO market with fil...
.Genentech will certainly close its own cancer immunology analysis department, as well as system min...
.Kezar Life Sciences is actually dropping its own unpromising phase 1 strong growth medicine as the ...
.In spite of izokibep maintaining its own newfound winning touch in the medical clinic, Acelyrin is ...
.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing drug candidat...
.Ovid Therapy actually uncovered last month that it was trimming its own head count as the provider ...
.Eli Lilly has opened a $700 thousand R&D center in the Boston ma Port, increasing its RNA and al...